Skip to main content
. 2015 May 12;2015(5):CD009080. doi: 10.1002/14651858.CD009080.pub2

Summary of findings for the main comparison. Vitrectomy compared to observation for idiopathic macular hole.

Vitrectomy compared to observation for idiopathic macular hole
Patient or population: participants with idiopathic macular hole
 Settings:Intervention: vitrectomy
 Comparison: observation
Outcomes Illustrative comparative risks* (95% CI) Relative effect
 (95% CI) No of Participants
 (studies) Quality of the evidence
 (GRADE) Comments
Assumed risk Corresponding risk
Observation Vitrectomy
Mean visual acuity (logMAR) at 6‐12 months 
 Follow‐up: 6‐12 months The mean visual acuity (logMAR) at 6‐12 months in the control groups was
 0.6 to 0.9 logMAR The mean visual acuity (logMAR) at 6‐12 months in the intervention groups was
 ‐0.16 logMAR better 
 (‐0.23 to ‐0.09) 270 eyes
 (3 studies) ⊕⊕⊕⊝
 moderate1
Hole closure at 6‐12 months 
 Follow‐up: 6‐12 months 110 per 1000 796 per 1000 
 (649 to 891) OR 31.4 
 (14.9 to 66.3) 265
 (3 studies) ⊕⊕⊕⊕
 high2
Reading acuity at 6 months The mean reading acuity at 6 months in the control groups was
 0.8 to 1.0 logMAR The mean reading acuity at 6 months in the intervention groups was
 ‐0.17 better 
 (‐0.26 to ‐0.07 better) 154
 (2 studies) ⊕⊕⊝⊝
 low1,3
Reading speed (word/minute) at 6 months The mean reading speed (word/minute) at 6 months in the control groups was
 36 words/minute The mean reading speed (word/minute) at 6 months in the intervention groups was
 5.6 lower 
 (14.42 lower to 3.22 higher) 118
 (1 study) ⊕⊕⊝⊝
 low1,3
Hole recurrence Data on macular hole recurrence after initially successful surgery could not be extracted from the studies.
Adverse outcomes Retinal detachment:Freeman 1997 reported no cases; Ezra 2004 described the retinal detachment rate for the vitrectomy groups only (vitrectomy alone or with serum), with values of 7/124 (5.6%), most detachments occurring in the first 6 weeks.
Symptomatic visual field defects (Ezra 2004) in the inferotemporal sector were found in 4/124 eyes (3.2%), with 15 eyes (12.1%) having asymptomatic defects.
Re‐operation (Ezra 2004): 18 (14.5%) of the surgical eyes, with subsequent hole closure in 78% of cases.
Costs Cost data were not available in the included studies.
*The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% confidence interval) is based on the assumed risk in the comparison group and the relative effect of the intervention (and its 95% CI).
 CI: confidence interval; OR: odds ratio
GRADE Working Group grades of evidence
 High quality: Further research is very unlikely to change our confidence in the estimate of effect.
 Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
 Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
 Very low quality: We are very uncertain about the estimate.

1 No or unclear masking of participant, physician, or outcome assessor (‐1)

2 No downgrade, as a result of no or unclear masking of outcome assessor in one study (‐1), but upgraded because of strong effect (+1)
 3 Wide confidence interval (‐1)